Mechanism: Hyalinosis and sclerosis lead to podocyte effacement.
4. Diabetic Nephropathy
Demographics: Patients with diabetes.
Mechanism: Non-enzymatic glycation causes arteriole sclerosis leading to increased intraglomerular pressure and podocyte damage.
5. Amyloidosis
Mechanism: Abnormal protein deposition due to chronic inflammation or multiple myeloma.
Diagnosis
Urinalysis:
Nephrotic Syndrome: Heavy proteinuria, lipiduria, fat oval bodies.
Nephritic Syndrome: Hematuria, pyuria, less protein loss.
Quantitative Tests:
24-hour urine protein or urine albumin-creatinine ratio to differentiate nephrotic (>3.5g) vs. nephritic (<3.5g).
Treatment
General Treatment Strategies
Complications:
Proteinuria: ACE inhibitors/ARBs to reduce protein loss and hypertension.
Hyperlipidemia: Dietary changes, statins.
Edema: Fluid/sodium restriction, diuretics.
Hypercoagulability: Anticoagulation therapy.
Vaccination against pneumococcus to reduce infection risk.
Specific Treatments
Primary Nephrotic Syndromes:
Minimal Change Disease: Steroids as first-line treatment; good response indicates minimal change.
Membranous Nephropathy & FSGS: Long-term immunosuppressants if steroids aren’t effective; risk of chronic kidney disease.
Secondary Causes
Must treat the underlying cause (e.g. infections, diabetes management, etc.).
Conclusion
Understanding nephrotic syndrome involves recognizing its presentation, differentiating types, and addressing both complications and underlying causes.